Deutsche Bank’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.63M Sell
19,135
-2,602
-12% -$358K ﹤0.01% 1537
2025
Q1
$3.92M Sell
21,737
-3,624
-14% -$653K ﹤0.01% 1354
2024
Q4
$3.97M Buy
25,361
+9,750
+62% +$1.53M ﹤0.01% 1433
2024
Q3
$2.84M Buy
15,611
+3,341
+27% +$608K ﹤0.01% 1536
2024
Q2
$2.25M Sell
12,270
-539
-4% -$99K ﹤0.01% 1561
2024
Q1
$2.28M Sell
12,809
-6,021
-32% -$1.07M ﹤0.01% 1574
2023
Q4
$2.34M Buy
18,830
+5,331
+39% +$661K ﹤0.01% 1581
2023
Q3
$1.57M Buy
13,499
+365
+3% +$42.3K ﹤0.01% 1460
2023
Q2
$1.54M Sell
13,134
-4,199
-24% -$493K ﹤0.01% 1750
2023
Q1
$1.39M Buy
17,333
+3,917
+29% +$314K ﹤0.01% 1896
2022
Q4
$1.06M Buy
13,416
+1,165
+10% +$92.3K ﹤0.01% 2014
2022
Q3
$854K Sell
12,251
-1,997
-14% -$139K ﹤0.01% 2057
2022
Q2
$936K Sell
14,248
-881
-6% -$57.9K ﹤0.01% 2226
2022
Q1
$1.01M Buy
15,129
+191
+1% +$12.7K ﹤0.01% 2326
2021
Q4
$1.04M Buy
14,938
+583
+4% +$40.7K ﹤0.01% 2401
2021
Q3
$749K Sell
14,355
-335
-2% -$17.5K ﹤0.01% 2779
2021
Q2
$999K Buy
14,690
+825
+6% +$56.1K ﹤0.01% 2759
2021
Q1
$1.07M Buy
13,865
+9
+0.1% +$693 ﹤0.01% 2612
2020
Q4
$832K Buy
13,856
+709
+5% +$42.6K ﹤0.01% 2554
2020
Q3
$566K Buy
13,147
+5,030
+62% +$217K ﹤0.01% 2553
2020
Q2
$336K Buy
8,117
+3,040
+60% +$126K ﹤0.01% 2816
2020
Q1
$220K Sell
5,077
-64
-1% -$2.77K ﹤0.01% 2875
2019
Q4
$283K Buy
5,141
+2,062
+67% +$114K ﹤0.01% 2995
2019
Q3
$105K Sell
3,079
-1,917
-38% -$65.4K ﹤0.01% 3452
2019
Q2
$200K Sell
4,996
-10,378
-68% -$415K ﹤0.01% 3746
2019
Q1
$505K Buy
+15,374
New +$505K ﹤0.01% 3394
2018
Q4
Sell
-22,930
Closed -$403K 4759
2018
Q3
$403K Buy
+22,930
New +$403K ﹤0.01% 3839